Lindsay L Devane

Title
InstitutionMedical University of South Carolina
DepartmentPsychiatry and Behavioral Sciences
AddressP.O. Box MSC514
405B
173 Ashley Ave.
Phone843-792-5448
Fax843-792-6318
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Lindsay DeVane C, Lindsay DeVane C. Women's Pharmacotherapy Matters. Pharmacotherapy. 2016 09; 36(9):953-4. PMID: 27650803.
      Citations:    
    2. DeVane CL, DeVane CL. Honoring Pharmacotherapy's Editorial Board. Pharmacotherapy. 2016 Jan; 36(1):11-2. PMID: 26799346.
      Citations:    
    3. DeVane CL, DeVane CL. The Art and Science of Reviewing the Pharmacotherapy Literature. Pharmacotherapy. 2015 Nov; 35(11):981-2. PMID: 26598089.
      Citations:    
    4. DeVane CL, DeVane CL. An epidemic of opioid prescriptions. Pharmacotherapy. 2015 Mar; 35(3):241-2. PMID: 25809174.
      Citations:    
    5. DeVane CL, DeVane CL. Behind the cover at Pharmacotherapy. Pharmacotherapy. 2014 Feb; 34(2):109-11. PMID: 24523095.
      Citations:    
    6. DeVane L, Goetzl LM, Ramamoorthy S, DeVane L, Goetzl LM, Ramamoorthy S. Exposing fetal drug exposure. Clin Pharmacol Ther. 2011 Jun; 89(6):786-8. PMID: 21593755.
      Citations:    
    7. DeVane CL, DeVane CL. Antidepressant-drug interactions are potentially but rarely clinically significant. Neuropsychopharmacology. 2006 Aug; 31(8):1594-604; discussion 1614-5. PMID: 16847446.
      Citations:    
    8. DeVane CL, Donovan JL, Liston HL, Markowitz JS, Cheng KT, Risch SC, Willard L, DeVane CL, Donovan JL, Liston HL, Markowitz JS, Cheng KT, Risch SC, Willard L. Comparative CYP3A4 inhibitory effects of venlafaxine, fluoxetine, sertraline, and nefazodone in healthy volunteers. J Clin Psychopharmacol. 2004 Feb; 24(1):4-10. PMID: 14709940.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    9. DeVane CL, DeVane CL. Immediate-release versus controlled-release formulations: pharmacokinetics of newer antidepressants in relation to nausea. J Clin Psychiatry. 2003; 64 Suppl 18:14-9. PMID: 14700450.
      Citations: 9     Fields:    Translation:Humans
    10. DeVane CL, Mintzer J, DeVane CL, Mintzer J. Risperidone in the management of psychiatric and neurodegenerative disease in the elderly: an update. Psychopharmacol Bull. 2003; 37(4):116-32. PMID: 15131522.
      Citations:    
    11. DeVane CL, DeVane CL. Pharmacokinetics, drug interactions, and tolerability of valproate. Psychopharmacol Bull. 2003; 37 Suppl 2:25-42. PMID: 14624231.
      Citations: 23     Fields:    Translation:HumansAnimals
    12. DeVane CL, Grothe DR, Smith SL, DeVane CL, Grothe DR, Smith SL. Pharmacology of antidepressants: focus on nefazodone. J Clin Psychiatry. 2002; 63 Suppl 1:10-7. PMID: 11890560.
      Citations: 3     Fields:    Translation:Humans
    13. DeVane CL, DeVane CL. Clinical significance of drug binding, protein binding, and binding displacement drug interactions. Psychopharmacol Bull. 2002; 36(3):5-21. PMID: 12473961.
      Citations: 6     Fields:    Translation:HumansCells
    14. Orr RK, Hoehn JL, Col NF, DeVane CL. Substance P: a new era, a new role. Pharmacotherapy. 2001 Sep; 21(9):1061-9. PMID: 11560196.
      Citations: 34     Fields:    Translation:HumansAnimalsCells
    15. DeVane CL, Markowitz JS, Carson SW, Boulton DW, Gill HS, Nahas Z, Risch SC, DeVane CL, Markowitz JS, Carson SW, Boulton DW, Gill HS, Nahas Z, Risch SC. Single-dose pharmacokinetics of methylphenidate in CYP2D6 extensive and poor metabolizers. J Clin Psychopharmacol. 2000 Jun; 20(3):347-9. PMID: 10831022.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    16. DeVane CL, DeVane CL. Pharmacologic characteristics of ideal antidepressants in the 21st century. J Clin Psychiatry. 2000; 61 Suppl 11:4-8. PMID: 10926049.
      Citations: 1     Fields:    Translation:Humans
    17. DeVane CL, Simpkins JW, Boulton DW, Laizure SC, Miller RL, DeVane CL, Simpkins JW, Boulton DW, Laizure SC, Miller RL. Disposition of morphine in tissues of the pregnant rat and foetus following single and continuous intraperitoneal administration to the mother. J Pharm Pharmacol. 1999 Nov; 51(11):1283-7. PMID: 10632086.
      Citations: 2     Fields:    Translation:Animals
    18. DeVane CL, Boulton DW, Miller LF, Miller RL, DeVane CL, Boulton DW, Miller LF, Miller RL. Pharmacokinetics of trazodone and its major metabolite m-chlorophenylpiperazine in plasma and brain of rats. Int J Neuropsychopharmacol. 1999 Mar; 2(1):17-23. PMID: 11281966.
      Citations: 7     Fields:    
    19. DeVane CL, DeVane CL. Differential pharmacology of newer antidepressants. J Clin Psychiatry. 1998; 59 Suppl 20:85-93. PMID: 9881541.
      Citations: 16     Fields:    Translation:HumansCells
    Devane's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (103)
    Explore
    _
    Co-Authors (2)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _